Search research articles
Contact Us
Filters
Showing results (81-90 of 132) with videos related to
Page
of 14
Sort By:
Blood
|
June 25, 1998
Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice
R K Kundu, F Sangiorgi, L Y Wu, et al.
The Journal of Pediatrics
|
March 1, 1985
Reduction of contact factors in sickle cell disease
E M Gordon, B L Klein, B W Berman, et al.
Human Gene Therapy
|
July 7, 2001
Lesion-targeted injectable vectors for vascular restenosis
E M Gordon, N L Zhu, M Forney Prescott, et al.
Journal of Medicinal Chemistry
|
June 1, 1991
Isoprenyl phosphinylformates: new inhibitors of squalene synthetase
S A Biller, C Forster, E M Gordon, et al.
Journal of Medicinal Chemistry
|
November 1, 1988
Design of novel inhibitors of aminopeptidases. Synthesis of peptide-derived diamino thiols and sulfur replacement analogues of bestatin
E M Gordon, J D Godfrey, N G Delaney, et al.
Kidney International
|
November 1, 1983
Effect of chronic metabolic acidosis on vitamin D metabolism in humans
J A Kraut, E M Gordon, J C Ransom, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie
|
May 9, 1998
Ability of retroviral transduction to modify the angiogenic characteristics of RPE cells
T Sakamoto, C Spee, Z Scuric, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Rational design and biochemical utility of specific inhibitors of angiotensin-converting enzyme
D W Cushman, M A Ondetti, E M Gordon, et al.
International Journal of Molecular Medicine
|
June 16, 2001
Long term inhibition of neointima formation in balloon-injured rat arteries by intraluminal instillation of a matrix-targeted retroviral vector bearing a cytocidal mutant cyclin G1 construct
F Xu, M F Prescott, P X Liu, et al.
Human Gene Therapy
|
May 16, 2000
Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor
F L Hall, L Liu, N L Zhu, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 132) with videos related to
Sort By:
Page
of 14
Blood
|
June 25, 1998
Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice
R K Kundu, F Sangiorgi, L Y Wu, et al.
The Journal of Pediatrics
|
March 1, 1985
Reduction of contact factors in sickle cell disease
E M Gordon, B L Klein, B W Berman, et al.
Human Gene Therapy
|
July 7, 2001
Lesion-targeted injectable vectors for vascular restenosis
E M Gordon, N L Zhu, M Forney Prescott, et al.
Journal of Medicinal Chemistry
|
June 1, 1991
Isoprenyl phosphinylformates: new inhibitors of squalene synthetase
S A Biller, C Forster, E M Gordon, et al.
Journal of Medicinal Chemistry
|
November 1, 1988
Design of novel inhibitors of aminopeptidases. Synthesis of peptide-derived diamino thiols and sulfur replacement analogues of bestatin
E M Gordon, J D Godfrey, N G Delaney, et al.
Kidney International
|
November 1, 1983
Effect of chronic metabolic acidosis on vitamin D metabolism in humans
J A Kraut, E M Gordon, J C Ransom, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie
|
May 9, 1998
Ability of retroviral transduction to modify the angiogenic characteristics of RPE cells
T Sakamoto, C Spee, Z Scuric, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Rational design and biochemical utility of specific inhibitors of angiotensin-converting enzyme
D W Cushman, M A Ondetti, E M Gordon, et al.
International Journal of Molecular Medicine
|
June 16, 2001
Long term inhibition of neointima formation in balloon-injured rat arteries by intraluminal instillation of a matrix-targeted retroviral vector bearing a cytocidal mutant cyclin G1 construct
F Xu, M F Prescott, P X Liu, et al.
Human Gene Therapy
|
May 16, 2000
Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor
F L Hall, L Liu, N L Zhu, et al.
Page
of 14